Level Four Advisory Services LLC Sells 14,825 Shares of Enovis Co. (NYSE:ENOV)

Level Four Advisory Services LLC lowered its holdings in shares of Enovis Co. (NYSE:ENOV) by 40.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,705 shares of the company’s stock after selling 14,825 shares during the period. Level Four Advisory Services LLC’s holdings in Enovis were worth $952,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of ENOV. Raymond James Financial Inc. bought a new position in shares of Enovis during the 4th quarter worth about $16,407,000. Boston Partners lifted its stake in Enovis by 27.1% during the fourth quarter. Boston Partners now owns 1,048,532 shares of the company’s stock worth $46,034,000 after purchasing an additional 223,816 shares during the period. Artemis Investment Management LLP grew its stake in shares of Enovis by 35.4% in the 4th quarter. Artemis Investment Management LLP now owns 665,868 shares of the company’s stock valued at $29,218,000 after purchasing an additional 174,116 shares during the period. DAVENPORT & Co LLC grew its stake in shares of Enovis by 6.0% in the 4th quarter. DAVENPORT & Co LLC now owns 2,782,341 shares of the company’s stock valued at $121,181,000 after purchasing an additional 157,216 shares during the period. Finally, Sei Investments Co. raised its holdings in shares of Enovis by 51.0% in the 4th quarter. Sei Investments Co. now owns 453,241 shares of the company’s stock worth $19,888,000 after buying an additional 153,006 shares in the last quarter. Institutional investors and hedge funds own 98.45% of the company’s stock.

Enovis Price Performance

Shares of Enovis stock opened at $37.74 on Monday. Enovis Co. has a 1-year low of $35.14 and a 1-year high of $62.79. The firm’s 50-day moving average price is $42.06 and its two-hundred day moving average price is $43.35. The company has a current ratio of 2.27, a quick ratio of 1.12 and a debt-to-equity ratio of 0.40. The stock has a market capitalization of $2.15 billion, a price-to-earnings ratio of -17.23 and a beta of 2.05.

Enovis (NYSE:ENOV) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.98 earnings per share for the quarter, beating analysts’ consensus estimates of $0.92 by $0.06. Enovis had a positive return on equity of 4.39% and a negative net margin of 5.95%. The firm had revenue of $560.98 million during the quarter, compared to analysts’ expectations of $555.14 million. On average, equities analysts predict that Enovis Co. will post 2.79 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Needham & Company LLC dropped their price objective on Enovis from $65.00 to $64.00 and set a “buy” rating for the company in a research note on Thursday, February 27th.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.